CARBONI, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 46.178
NA - Nord America 1.706
AS - Asia 224
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 48.115
Nazione #
IT - Italia 45.829
US - Stati Uniti d'America 1.695
CN - Cina 165
UA - Ucraina 128
SE - Svezia 88
SG - Singapore 48
FI - Finlandia 34
GB - Regno Unito 34
DE - Germania 30
FR - Francia 15
CA - Canada 11
RU - Federazione Russa 6
BE - Belgio 4
NL - Olanda 4
VN - Vietnam 4
BR - Brasile 3
KR - Corea 3
ES - Italia 2
EU - Europa 2
IE - Irlanda 2
AU - Australia 1
IN - India 1
JP - Giappone 1
KG - Kirghizistan 1
NG - Nigeria 1
NO - Norvegia 1
PL - Polonia 1
TR - Turchia 1
Totale 48.115
Città #
Cagliari 45.204
Uta 527
Fairfield 245
Woodbridge 196
Houston 159
Chandler 136
Ashburn 107
Wilmington 106
Seattle 104
Ann Arbor 84
Cambridge 72
Nyköping 70
Jacksonville 68
Boardman 65
Dearborn 52
Shanghai 42
New York 40
Singapore 32
Nanjing 29
Santa Clara 22
Boston 18
Helsinki 15
Jiaxing 11
Redwood City 11
Beijing 10
Milan 10
San Diego 10
Toronto 10
Changsha 7
Jinan 7
Shenyang 7
Verona 7
London 6
Los Angeles 6
Nanchang 6
Rome 5
Dong Ket 4
Guangzhou 4
Hebei 4
Hefei 4
Mountain View 4
Zhengzhou 4
Arezzo 3
Auburn Hills 3
Liedekerke 3
Livorno 3
New Bedfont 3
Orange 3
Seoul 3
Taranto 3
Tianjin 3
Washington 3
Atlanta 2
Castello di Cisterna 2
Chengdu 2
Cipó 2
Dublin 2
Florence 2
Madrid 2
Mira 2
Ningbo 2
Norwalk 2
Padova 2
Saint Paul 2
Saint Petersburg 2
Taizhou 2
Trieste 2
Wuhan 2
Amsterdam 1
Bend 1
Berlin 1
Bishkek 1
Borås 1
Brussels 1
Changchun 1
Fremont 1
Haikou 1
Indiana 1
Istanbul 1
Kilburn 1
Kunming 1
Lagos 1
Leawood 1
Melbourne 1
Munich 1
Naples 1
North Bergen 1
North York 1
Oslo 1
Paese 1
Phoenix 1
Quartu Sant'elena 1
Ravenna 1
Secaucus 1
São Paulo 1
Tokyo 1
Treviso 1
Wuxi 1
Yellow Springs 1
Totale 47.623
Nome #
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.062
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.765
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.676
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.094
Influence of treatments in multiple sclerosis disability: a cohort study 3.046
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.619
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.498
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.199
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.194
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.174
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.096
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.007
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 1.920
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.804
The empowerment of translational research: lessons from laminopathies. 1.560
A Novel Mutation in Lamin A/C Gene: Phenotype and Consequences on the Protein Structure and Flexibility 1.489
A novel mutation in the central rod domain of lamin A/C producing a phenotype resembling the Emery-Dreifuss muscular dystrophy phenotype 1.470
Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations. 1.390
Unusual clinical presentations in subjects carrying novel NOTCH3 gene mutations 1.377
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14 1.253
Treatment of refractory chronic inflammatory demyelinating polyneuropathy with interferon beta1B 743
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. 727
Totale 48.163
Categoria #
all - tutte 55.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.743 0 0 0 0 3.931 2.432 1.165 280 173 183 147 432
2020/202112.329 296 448 471 3.698 2.368 1.384 824 797 325 723 646 349
2021/20223.193 410 187 111 260 308 224 123 104 301 345 515 305
2022/20233.552 292 558 584 288 350 389 110 215 186 207 240 133
2023/20242.770 120 198 106 201 259 439 399 251 117 186 242 252
2024/20254.199 1.543 1.451 516 480 209 0 0 0 0 0 0 0
Totale 48.163